Literature DB >> 23607618

NMR structure of calmodulin complexed to an N-terminally acetylated α-synuclein peptide.

James M Gruschus1, Thai Leong Yap, Sara Pistolesi, Alexander S Maltsev, Jennifer C Lee.   

Abstract

Calmodulin (CaM) is a calcium binding protein that plays numerous roles in Ca-dependent cellular processes, including uptake and release of neurotransmitters in neurons. α-Synuclein (α-syn), one of the most abundant proteins in central nervous system neurons, helps maintain presynaptic vesicles containing neurotransmitters and moderates their Ca-dependent release into the synapse. Ca-Bound CaM interacts with α-syn most strongly at its N-terminus. The N-terminal region of α-syn is important for membrane binding; thus, CaM could modulate membrane association of α-syn in a Ca-dependent manner. In contrast, Ca-free CaM has negligible interaction. The interaction with CaM leads to significant signal broadening in both CaM and α-syn NMR spectra, most likely due to conformational exchange. The broadening is much reduced when binding a peptide consisting of the first 19 residues of α-syn. In neurons, most α-syn is acetylated at the N-terminus, and acetylation leads to a 10-fold increase in binding strength for the α-syn peptide (KD = 35 ± 10 μM). The N-terminally acetylated peptide adopts a helical structure at the N-terminus with the acetyl group contacting the N-terminal domain of CaM and with less ordered helical structure toward the C-terminus of the peptide contacting the CaM C-terminal domain. Comparison with known structures shows that the CaM/α-syn complex most closely resembles Ca-bound CaM in a complex with an IQ motif peptide. However, a search comparing the α-syn peptide sequence with known CaM targets, including IQ motifs, found no homologies; thus, the N-terminal α-syn CaM binding site appears to be a novel CaM target sequence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23607618      PMCID: PMC3758425          DOI: 10.1021/bi400199p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  57 in total

1.  Recognition pliability is coupled to structural heterogeneity: a calmodulin intrinsically disordered binding region complex.

Authors:  Malini Nagulapalli; Giacomo Parigi; Jing Yuan; Joerg Gsponer; George Deraos; Vladimir V Bamm; George Harauz; John Matsoukas; Maurits R R de Planque; Ioannis P Gerothanassis; M Madan Babu; Claudio Luchinat; Andreas G Tzakos
Journal:  Structure       Date:  2012-03-07       Impact factor: 5.006

2.  The Xplor-NIH NMR molecular structure determination package.

Authors:  Charles D Schwieters; John J Kuszewski; Nico Tjandra; G Marius Clore
Journal:  J Magn Reson       Date:  2003-01       Impact factor: 2.229

3.  Calcium-dependent regulation of SNARE-mediated membrane fusion by calmodulin.

Authors:  Jerome Di Giovanni; Cécile Iborra; Yves Maulet; Christian Lévêque; Oussama El Far; Michael Seagar
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

Review 4.  Neuronal calcium signaling.

Authors:  M J Berridge
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

5.  Role of calmodulin as a regulator of Ca2+-dependent exocytosis in adrenal chromaffin cells.

Authors:  H C Palfrey; C R Artalejo
Journal:  Pflugers Arch       Date:  1997-11       Impact factor: 3.657

6.  Calmodulin controls synaptic strength via presynaptic activation of calmodulin kinase II.

Authors:  Zhiping P Pang; Peng Cao; Wei Xu; Thomas C Südhof
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

7.  α-Synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers.

Authors:  David C DeWitt; Elizabeth Rhoades
Journal:  Biochemistry       Date:  2013-03-27       Impact factor: 3.162

8.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

9.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Authors:  K Uéda; H Fukushima; E Masliah; Y Xia; A Iwai; M Yoshimoto; D A Otero; J Kondo; Y Ihara; T Saitoh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  12 in total

1.  Synthesis of thioester peptides for the incorporation of thioamides into proteins by native chemical ligation.

Authors:  Solongo Batjargal; Yun Huang; Yanxin J Wang; E James Petersson
Journal:  J Pept Sci       Date:  2014-01-09       Impact factor: 1.905

2.  Neurogranin binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease.

Authors:  Andrew O Koob; Gideon M Shaked; Andreas Bender; Alejandro Bisquertt; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Res       Date:  2014-10-19       Impact factor: 3.252

Review 3.  The biological functions of Naa10 - From amino-terminal acetylation to human disease.

Authors:  Max J Dörfel; Gholson J Lyon
Journal:  Gene       Date:  2015-05-16       Impact factor: 3.688

4.  Structural and thermodynamic characterization of the recognition of the S100-binding peptides TRTK12 and p53 by calmodulin.

Authors:  Lucas N Wafer; Franco O Tzul; Pranav P Pandharipande; Scott A McCallum; George I Makhatadze
Journal:  Protein Sci       Date:  2014-07-02       Impact factor: 6.725

Review 5.  Characterizing Post-Translational Modifications and Their Effects on Protein Conformation Using NMR Spectroscopy.

Authors:  Ajith Kumar; Vaishali Narayanan; Ashok Sekhar
Journal:  Biochemistry       Date:  2019-11-04       Impact factor: 3.162

Review 6.  Alpha-synuclein function and dysfunction on cellular membranes.

Authors:  David Snead; David Eliezer
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

7.  Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease.

Authors:  James M Gruschus
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

8.  In vitro aggregation assays for the characterization of α-synuclein prion-like properties.

Authors:  Joanna Narkiewicz; Gabriele Giachin; Giuseppe Legname
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

9.  N-Lauroylation during the Expression of Recombinant N-Myristoylated Proteins: Implications and Solutions.

Authors:  Andrea Gabriele Flamm; Anabel-Lise Le Roux; Borja Mateos; Mireia Díaz-Lobo; Barbara Storch; Kathrin Breuker; Robert Konrat; Miquel Pons; Nicolas Coudevylle
Journal:  Chembiochem       Date:  2015-12-03       Impact factor: 3.164

10.  Abundant fish protein inhibits α-synuclein amyloid formation.

Authors:  Tony Werner; Ranjeet Kumar; Istvan Horvath; Nathalie Scheers; Pernilla Wittung-Stafshede
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.